Patent details

EP2368554 Title: Pharmaceutical formulations containing methylnaltrexone

Basic Information

Publication number:
EP2368554
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP101846848
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Pharmaceutical formulations containing methylnaltrexone
French Title of Invention:
Formulations pharmaceutiques contenant de la methylnaltrexone
German Title of Invention:
Pharmazeutische Formulierungen enthaltend Methylnaltrexon
SPC Number:

Dates

Filing date:
08/04/2004
Grant date:
24/12/2014
EP Publication Date:
24/12/2014
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/09/2011
EP B1 Publication Date:
24/12/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
08/04/2024
Renunciation date:
Revocation date:
13/11/2020
Annulment date:

Owner

From:
08/04/2004
 
 

Name:
Progenics Pharmaceuticals Inc.
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
14/01/2015
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Boyd Thomas
Address:
United States (US)

2

Name:
Sanghvi Suketu
Address:
United States (US)

Priority

Priority Number:
461611 P
Priority Date:
08/04/2003
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/485;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2021/01
Publication date:
05/01/2021
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

Issue number:
202053
Publication date:
30/12/2020
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
20/03/2020
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
246 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages